WO2010037688A1 - Process for the synthesis of halogenated cyclic compounds - Google Patents

Process for the synthesis of halogenated cyclic compounds Download PDF

Info

Publication number
WO2010037688A1
WO2010037688A1 PCT/EP2009/062462 EP2009062462W WO2010037688A1 WO 2010037688 A1 WO2010037688 A1 WO 2010037688A1 EP 2009062462 W EP2009062462 W EP 2009062462W WO 2010037688 A1 WO2010037688 A1 WO 2010037688A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
process according
compound
alkyl group
group
Prior art date
Application number
PCT/EP2009/062462
Other languages
French (fr)
Inventor
Max Braun
Original Assignee
Solvay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Sa filed Critical Solvay Sa
Priority to CN2009801384364A priority Critical patent/CN102164898A/en
Priority to US13/120,505 priority patent/US8431710B2/en
Priority to KR1020197018768A priority patent/KR20190080972A/en
Priority to JP2011529509A priority patent/JP6180705B2/en
Priority to KR1020167031136A priority patent/KR20160131129A/en
Priority to CA2735921A priority patent/CA2735921C/en
Priority to EP09783436.0A priority patent/EP2334645B1/en
Publication of WO2010037688A1 publication Critical patent/WO2010037688A1/en
Priority to US13/872,860 priority patent/US8981115B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/803—Processes of preparation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Definitions

  • the present invention relates to a process for the synthesis of halogenated cyclic compounds.
  • Halogenated cyclic compounds are useful for example as intermediates for the preparation of various herbicides, insecticides, miticides, pesticides etc.
  • U.S. patent application US 2006/0128702 Al describes the synthesis of 3-trifluoromethyl-lH-Pyrazole (TFPZO) by reacting 4-ethoxy- 1,1,1 -trifluoro- 3-buten-2-one with hydrazine dihydrochloride.
  • Atherton and Fields, J. Chem. Soc. (C), 1968, p.1507-1513 describe the synthesis of 3-trifluoromethyl-lH-Pyrazole from 2,2,2-trifluorodiazoethane.
  • the TFPZO compound is used as intermediate in chemical synthesis.
  • European patent application EP-A- 163280 discloses the manufacture of 2-hydroxy-4- trifluoromethyl pyrimidine (TFPMO) from the reaction product of TFAH with EVE.
  • TFPMO 2-hydroxy-4- trifluoromethyl pyrimidine
  • the TFPMO compound is used as intermediate in chemical synthesis, to produce pyrimidinylphosphates as pesticides. It is an object of the present invention to provide an efficient process for manufacturing halogenated cyclic compounds, in particular halogenated nitrogen containing heterocycles which allows for good yields and product purities, starting from readily available starting materials.
  • the invention concerns in consequence a process for the manufacture of a cyclic compound of formula (I) :
  • Ri is a halogenated alkyl group Z and Y designate independently carbon or a heteroatom
  • the addition product of an acid halide in particular acid chloride with a vinyl ether as specified above is particularly suitable as starting material for producing cyclic compounds as detailed above.
  • Overall yield starting from acid halide and vinyl ether is good.
  • a purification of the addition product may be unnecessary before further reaction.
  • the addition product, in particular if hydrogen halide is present, may increase the reaction rate in the reaction with the compound of formula (III) and allow for easier separation of the cyclic compound produced from the reaction mixture, in particular when a nitrogen-containing heterocycle is produced.
  • Rl preferably contains at least 1, more preferably 2 fluorine atoms.
  • Rl is a perfluoroalkyl group.
  • Rl is often a Cl to C3 halogenated alkyl group, preferably a Cl to C3 fluorinated alkyl group, in particular as described here before.
  • Rl is more preferably a Cl fluorinated alkyl group selected in particular from CF3, CF 2 H and CF 2 Cl.
  • a CF 3 group is more particularly preferred.
  • Rl preferably contains at least 1, more preferably 2 fluorine atoms and at least 1 other halogen atom.
  • Rl is more preferably a fluorinated Cl alkyl group selected in particular from CF 2 Br and CF 2 Cl.
  • X is often selected from Cl and Br and is more preferably Cl.
  • Acid halides used in the present invention can be obtained, for example, by photo xidation of halogenated precursor alkanes, in particular as described in US 5,569,782 the contents of which is incorporated by reference in the present application.
  • trifluoro acetyl chloride which is a particularly preferred starting material in the present invention, can be obtained by photooxidation of 1,1,1 -Trifluoro-2,2-dichloroethane (HCFC-123).
  • R 2 is often selected from a Cl to C4 alkyl group, preferably a methyl, an ethyl, an isopropyl or a n-butyl group and is more preferably an ethyl group.
  • the acid halide is trifluoro acetyl chloride and the vinyl ether is ethyl vinyl ether or methyl vinyl ether, more preferably ethyl vinyl ether.
  • Z and Y can be independently selected from oxygen, sulphur, nitrogen and carbon. The process according to the invention applies in particularly advantageous manner when at least one of Z and Y is nitrogen.
  • Z and/or Y are selected from -NH2, -NHR3, wherein R3 is an alkyl aryl or aralkyl residue, preferably a Cl to C6 alkyl, or hydrogen halide salts thereof, -OH, -SH and donor carbon atoms for example a CH2 group in ⁇ -position to a carbonyl function such as a keto or ester group.
  • A is a linking group between Z and Y.
  • Such linking group can simply be a covalent bond, in which case A contains 0 atoms.
  • the linking group A can also contain 1, 2 or 3 atoms, which form part of the ring (annular atoms) when A forms part of the structure of compound (I) and which are catenary (i.e. in the chain linking Z and Y) when A forms part of the structure of compound (III).
  • A comprises 1 or 2 catenary/annular atoms, in particular, optionally substituted carbon atoms.
  • compound of formula (III) are selected from hydrazine or its hydrate or hydrochloride, urea, thiourea, malonic acid monoamide (for example methyl or ethyl ester of malonic acid monoamide), and malomononitrile (2-cyano-acetic acid alkyl ester, for example methyl or ethyl ester).
  • step (b) comprises 1 catenary/annular atoms, optionally substituted carbon atoms.
  • the reaction of step (b) is generally carried out at a temperature in the range from -15° C to +80 0 C, preferably from 0° C to +20 0 C.
  • the reaction of step (b) can be carried out in the presence of a non-hindered amine.
  • Non-hindered amines refers to chemical compounds containing an amine functional group bonded to non- sterically hindering groups.
  • Typical examples of non-sterically hindering groups are short linear aliphatic groups such as methyl, ethyl, propyl and n-butyl
  • Typical examples of non-hindered amines are for example methylamine, diethylamine, triethylamine and tri-n-butylamine. Triethylamine is most preferred non- hindered amine.
  • the molar ratio of the non- hindered amine to the compound of formula (III) is advantageously from 0.5:1 to 1.7:1, preferably from 0.6:1 to 1.5:1, and more preferably from 0.8:1 to 1.2:1. Most preferably, the molar ratio is about 1.
  • the reaction of step (b) can optionally be carried out in the presence of an additive. Such additive generally increases the polarity of the reaction medium. Ionic liquids can be suitably used as additives.
  • additives are for instance 1,3-dialkylimidazolium or 1,3-dialkyl piridinium salts in particular l-ethyl-3- methylimidazolium trifluoromethanesulfonate (EMIMOtf).
  • Amines such as 4-Dimethylaminopyridine (DMAP), Diazabicyclo [5.4.0] undec-7-ene (DBU) and Diazabicyclononan (DBN) as such or under salt form, for example as trifluoro acetic acid salt can also be suitably used as additive.
  • DMAP 4-Dimethylaminopyridine
  • DBU Diazabicyclo [5.4.0] undec-7-ene
  • DBN Diazabicyclononan
  • the term "ionic liquid” refers to a homogeneous composition consisting of a single salt (one cationic species and one anionic species) or it may refer to a heterogeneous composition containing more than one species of cation and/or more than one species of anion.
  • the reaction of step (b) is often carried out in an organic solvent, in particular a polar organic solvent.
  • Alcohols such as methanol or ethanol give good results in the reaction of step (b). Methanol is particularly preferred.
  • the process according to the invention suitably further comprises isolating the compound of formula (I) from the reaction medium of step (b) by solid/liquid separation, for example filtration or by distillation.
  • the addition product comprises a compound of formula (IV) :
  • the addition product comprises a compound of formula (V) :
  • R 2 is as defined above.
  • the addition product comprises a compound of formula (IV) or (V)
  • its content is generally at least 0.1 wt. % relative to the total weight of addition product. Often this content is at least 0.5 %. In some embodiments this content does not exceed 10 wt. %.
  • the addition product can also consist essentially of compound of formula (IV) or (V). In this case its content is generally from 90-99.9, often from 95 to 99.0 wt. % relative to the total weight of addition product.
  • the addition product comprises a compound of formula (VI) :
  • the addition product comprises a compound of formula (VII) :
  • R 2 is as defined above.
  • the compounds of formulae (VI) and (VII) can be obtained preferably by a process comprising (a) adding, as described above, acid halide to vinyl ether to obtain a reaction product comprising compound of formula (IV) or (V) and (b) eliminating hydrogen halide to produce a compound of formula (VI) or (VII) respectively.
  • Such reaction can be carried out in the presence of base such as described in US patent 5,708,174 or, preferably, in the absence of base such as described in US patent 7,405,328, the entire contents of said two US patents being incorporated by reference into the present application.
  • the addition product comprises a compound of formula (VI) or (VII)
  • its content is generally at least 0.1 wt. % relative to the total weight of addition product. Often this content is at least 0.5 %. In some embodiments this content does not exceed 10 wt. %.
  • the addition product can also consist essentially of compound of formula (VI) or (VII). In this case its content is generally from 90-99.9, often from 95 to 99.0 wt. % relative to the total weight of addition product.
  • the addition product can be a mixture of compounds of formula (IV) and (VI) or (V) and (VII) respectively.
  • the molar ratio between compounds (IV) and (V) on the one hand and (VI ) and (VII) on the other hand is generally from 0.01 to 100, preferably from O.l to lO.
  • HX, in particular HCl is fed to step (b).
  • HX, in particular HCl, produced in step (a) may suitably be fed to step (b).
  • at least one of Z or Y is nitrogen, it has been found that it is possible to precipitate the heterocycle from the reaction medium of step (b) by addition of HX in particular HCl and to isolate it for example by filtration.
  • the HX addition can be carried out, for example during reaction or during work-up.
  • the invention also concerns a process for the synthesis of a cyclic compound of formula (I) :
  • Ri is a halogenated alkyl group Z and Y designate independently carbon or a heteroatom
  • Example 1 Manufacture of 6-(trifluoromethyl)pyrimidin-2( 1 H)-on To a solution of 8.74 moles of urea in 2.2L of methanol in a 3-necked flask, equipped with a mechanical stirrer, a reflux condenser and a dropping funnel was added dropwise over about 3 hours under N 2 atmosphere an equimolar amount of 4-ethoxy- 1,1,1 -trifluoro-3-buten-2-one (ETFBO) which had been manufactured by addition of trifluoroacetyl chloride to ethyl vinyl ether. The temperature of the reaction mixture was kept below 15 0 C.
  • ETFBO 4-ethoxy- 1,1,1 -trifluoro-3-buten-2-one
  • CETFBO could be obtained quantitatively without any elimination of HCl.
  • 6-(trifluoromethyl)pyrimidin-2( lH)-on was obtained as pale beige crystals which were filtered off and washed with water. After drying on a rotary evaporator under reduced pressure, 6-(trifluoromethyl)pyrimidin-2(lH)-on was obtained in 82 % yield.
  • Example 4 6-(trifluoromethyl)pyrimidin-2( lH)-on was obtained as pale beige crystals which were filtered off and washed with water. After drying on a rotary evaporator under reduced pressure, 6-(trifluoromethyl)pyrimidin-2(lH)-on was obtained in 82 % yield.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)

Abstract

Process for the synthesis of halogenated cyclic compounds A process for the manufacture of a cyclic compound of formula (I) wherein R1 is a halogenated alkyl group Z and Y designate independently carbon or a heteroatom A is a linking group between Z and Y comprising 0, 1, 2 or 3 atoms in the cycle which comprises (a) adding an acid halide of formula R1-C (O)-X wherein X = fluorine, chlorine or bromine and R1 has the meaning given above, to a vinyl ether of formula (II) CH2 =CH-OR2 (II) wherein R2 is an alkyl group, an aralkyl group or an aryl group to produce an addition product and (b) said addition product is reacted with a compound of formula (III) Y-A-Z (III), Z, Y and A are as defined above.

Description

Process for the synthesis of halogenated cyclic compounds
The present invention relates to a process for the synthesis of halogenated cyclic compounds.
Halogenated cyclic compounds are useful for example as intermediates for the preparation of various herbicides, insecticides, miticides, pesticides etc. U.S. patent application US 2006/0128702 Al describes the synthesis of 3-trifluoromethyl-lH-Pyrazole (TFPZO) by reacting 4-ethoxy- 1,1,1 -trifluoro- 3-buten-2-one with hydrazine dihydrochloride. Atherton and Fields, J. Chem. Soc. (C), 1968, p.1507-1513 describe the synthesis of 3-trifluoromethyl-lH-Pyrazole from 2,2,2-trifluorodiazoethane. The TFPZO compound is used as intermediate in chemical synthesis. European patent application EP-A- 163280 discloses the manufacture of 2-hydroxy-4- trifluoromethyl pyrimidine (TFPMO) from the reaction product of TFAH with EVE. The TFPMO compound is used as intermediate in chemical synthesis, to produce pyrimidinylphosphates as pesticides. It is an object of the present invention to provide an efficient process for manufacturing halogenated cyclic compounds, in particular halogenated nitrogen containing heterocycles which allows for good yields and product purities, starting from readily available starting materials.
The invention concerns in consequence a process for the manufacture of a cyclic compound of formula (I) :
Figure imgf000002_0001
wherein Ri is a halogenated alkyl group Z and Y designate independently carbon or a heteroatom A is a linking group between Z and Y comprising 0, 1, 2 or 3 atoms in the cycle which comprises (a) adding an acid halide of formula Ri-C (O)-X wherein X = fluorine, chlorine or bromine and Ri has the meaning given above, to a vinyl ether of formula (II) CH2 =CH-OR2 (II) wherein R2 is an alkyl group, an aralkyl group or an aryl group to produce an addition product and (b) said addition product is reacted with a compound of formula (III) Y-A-Z (III), Z , Y and A are as defined above.
It has been found, surprisingly, that the addition product of an acid halide, in particular acid chloride with a vinyl ether as specified above is particularly suitable as starting material for producing cyclic compounds as detailed above. Overall yield starting from acid halide and vinyl ether is good. A purification of the addition product may be unnecessary before further reaction. The addition product, in particular if hydrogen halide is present, may increase the reaction rate in the reaction with the compound of formula (III) and allow for easier separation of the cyclic compound produced from the reaction mixture, in particular when a nitrogen-containing heterocycle is produced.
In the process according to the invention, Rl preferably contains at least 1, more preferably 2 fluorine atoms. In one preferred aspect Rl is a perfluoroalkyl group. Rl is often a Cl to C3 halogenated alkyl group, preferably a Cl to C3 fluorinated alkyl group, in particular as described here before. Rl is more preferably a Cl fluorinated alkyl group selected in particular from CF3, CF2H and CF2Cl. A CF3 group is more particularly preferred.
In another aspect, Rl preferably contains at least 1, more preferably 2 fluorine atoms and at least 1 other halogen atom. Rl is more preferably a fluorinated Cl alkyl group selected in particular from CF2Br and CF2Cl.
In the process according to the invention, X is often selected from Cl and Br and is more preferably Cl.
Acid halides used in the present invention can be obtained, for example, by photo xidation of halogenated precursor alkanes, in particular as described in US 5,569,782 the contents of which is incorporated by reference in the present application. In particular, trifluoro acetyl chloride, which is a particularly preferred starting material in the present invention, can be obtained by photooxidation of 1,1,1 -Trifluoro-2,2-dichloroethane (HCFC-123).
In the process according to the invention, R2 is often selected from a Cl to C4 alkyl group, preferably a methyl, an ethyl, an isopropyl or a n-butyl group and is more preferably an ethyl group.
Consequently, in a most preferred aspect, the acid halide is trifluoro acetyl chloride and the vinyl ether is ethyl vinyl ether or methyl vinyl ether, more preferably ethyl vinyl ether. In the process according to the invention Z and Y can be independently selected from oxygen, sulphur, nitrogen and carbon. The process according to the invention applies in particularly advantageous manner when at least one of Z and Y is nitrogen.
It is understood that it is appropriate that in the compound Z-A-Y, Z and Y be under a form which enables them to react in the reaction of step (b). For example, suitably, Z and/or Y are selected from -NH2, -NHR3, wherein R3 is an alkyl aryl or aralkyl residue, preferably a Cl to C6 alkyl, or hydrogen halide salts thereof, -OH, -SH and donor carbon atoms for example a CH2 group in α-position to a carbonyl function such as a keto or ester group.
In the process according to the invention, A is a linking group between Z and Y. Such linking group can simply be a covalent bond, in which case A contains 0 atoms. The linking group A can also contain 1, 2 or 3 atoms, which form part of the ring (annular atoms) when A forms part of the structure of compound (I) and which are catenary (i.e. in the chain linking Z and Y) when A forms part of the structure of compound (III). Preferably, A comprises 1 or 2 catenary/annular atoms, in particular, optionally substituted carbon atoms. In the latter case, A is suitably selected from -CH2-, -C(=O)-, -CH2-CH2 and CH2-C(=O)- and -C(=S)-.
Particular examples of compound of formula (III) are selected from hydrazine or its hydrate or hydrochloride, urea, thiourea, malonic acid monoamide (for example methyl or ethyl ester of malonic acid monoamide), and malomononitrile (2-cyano-acetic acid alkyl ester, for example methyl or ethyl ester).
It is understood that the teaching of the present invention enables the skilled person to select the appropriate combination of the various groups Rl, Z, Y and A of the formulae (I) and (III) on account of the desired cyclic compound and the known reactivity and valency of the respective groups.
The process according to the invention can be suitably used for the manufacture of the compounds of formula (I) according to the invention corresponding more specifically to one of the formulae
Figure imgf000004_0001
IX X - A -
wherein A comprises 1 catenary/annular atoms, optionally substituted carbon atoms. In the latter case, A is suitably selected from -CH2-, -C(=O)-, -CH2-CH2 and CH2-C(=O)- and -C(=S)- wherein R3 is H or a Cl to C6 alkyl In the process according to the invention, the reaction of step (b) is generally carried out at a temperature in the range from -15° C to +800C, preferably from 0° C to +200C.
In the process according to the invention, the reaction of step (b) can be carried out in the presence of a non-hindered amine. Non-hindered amines refers to chemical compounds containing an amine functional group bonded to non- sterically hindering groups. Typical examples of non-sterically hindering groups are short linear aliphatic groups such as methyl, ethyl, propyl and n-butyl Typical examples of non-hindered amines are for example methylamine, diethylamine, triethylamine and tri-n-butylamine. Triethylamine is most preferred non- hindered amine.
In the process according to the invention, the molar ratio of the non- hindered amine to the compound of formula (III) is advantageously from 0.5:1 to 1.7:1, preferably from 0.6:1 to 1.5:1, and more preferably from 0.8:1 to 1.2:1. Most preferably, the molar ratio is about 1. In the process according to the invention, the reaction of step (b) can optionally be carried out in the presence of an additive. Such additive generally increases the polarity of the reaction medium. Ionic liquids can be suitably used as additives. Typical examples of additives are for instance 1,3-dialkylimidazolium or 1,3-dialkyl piridinium salts in particular l-ethyl-3- methylimidazolium trifluoromethanesulfonate (EMIMOtf). Amines such as 4-Dimethylaminopyridine (DMAP), Diazabicyclo [5.4.0] undec-7-ene (DBU) and Diazabicyclononan (DBN) as such or under salt form, for example as trifluoro acetic acid salt can also be suitably used as additive.
For the purpose of the present invention, the term "ionic liquid" refers to a homogeneous composition consisting of a single salt (one cationic species and one anionic species) or it may refer to a heterogeneous composition containing more than one species of cation and/or more than one species of anion.
In the process according to the invention, the reaction of step (b) is often carried out in an organic solvent, in particular a polar organic solvent. Alcohols such as methanol or ethanol give good results in the reaction of step (b). Methanol is particularly preferred. The process according to the invention suitably further comprises isolating the compound of formula (I) from the reaction medium of step (b) by solid/liquid separation, for example filtration or by distillation.
In a first embodiment of the process according to the invention the addition product comprises a compound of formula (IV) :
Figure imgf000006_0001
wherein X, Ri and R2 are as defined above.
In a preferred aspect of this first embodiment the addition product comprises a compound of formula (V) :
Figure imgf000006_0002
wherein R2 is as defined above.
Compounds of formulae (IV) and (V) can be advantageously used as starting materials to form cyclic compounds, in particular in accordance with the process according to the invention. The invention concerns in consequence also the use of a compound of formula (IV) or (V) as reagent in an addition reaction to form a cyclic compound.
When the addition product comprises a compound of formula (IV) or (V), its content is generally at least 0.1 wt. % relative to the total weight of addition product. Often this content is at least 0.5 %. In some embodiments this content does not exceed 10 wt. %.
The addition product can also consist essentially of compound of formula (IV) or (V). In this case its content is generally from 90-99.9, often from 95 to 99.0 wt. % relative to the total weight of addition product.
In a second embodiment of the process according to the invention, the addition product comprises a compound of formula (VI) :
Figure imgf000006_0003
wherein Ri and R2 are as defined above.
In a preferred aspect of the second embodiment, the addition product comprises a compound of formula (VII) :
Figure imgf000007_0001
wherein R2 is as defined above.
The compounds of formulae (VI) and (VII) can be obtained preferably by a process comprising (a) adding, as described above, acid halide to vinyl ether to obtain a reaction product comprising compound of formula (IV) or (V) and (b) eliminating hydrogen halide to produce a compound of formula (VI) or (VII) respectively. Such reaction can be carried out in the presence of base such as described in US patent 5,708,174 or, preferably, in the absence of base such as described in US patent 7,405,328, the entire contents of said two US patents being incorporated by reference into the present application.
When the addition product comprises a compound of formula (VI) or (VII), its content is generally at least 0.1 wt. % relative to the total weight of addition product. Often this content is at least 0.5 %. In some embodiments this content does not exceed 10 wt. %.
The addition product can also consist essentially of compound of formula (VI) or (VII). In this case its content is generally from 90-99.9, often from 95 to 99.0 wt. % relative to the total weight of addition product.
In the process according to the invention, the addition product can be a mixture of compounds of formula (IV) and (VI) or (V) and (VII) respectively. In this case the molar ratio between compounds (IV) and (V) on the one hand and (VI ) and (VII) on the other hand is generally from 0.01 to 100, preferably from O.l to lO.
In particular, when the addition reaction in the process according to the invention is carried out in the absence of base, it is possible to provide a crude product from the addition reaction (a) to the reaction (b). In addition to the addition product as described here before such crude product may notably contain hydrogen halide, in particular hydrogen chloride.
In one particular embodiment of the process according to the invention, HX, in particular HCl is fed to step (b). In particular such HX, in particular HCl, produced in step (a) may suitably be fed to step (b). In particular in this embodiment and more particularly when in addition at least one of Z or Y is nitrogen, it has been found that it is possible to precipitate the heterocycle from the reaction medium of step (b) by addition of HX in particular HCl and to isolate it for example by filtration. The HX addition can be carried out, for example during reaction or during work-up.
The invention also concerns a process for the synthesis of a cyclic compound of formula (I) :
Figure imgf000008_0001
wherein Ri is a halogenated alkyl group Z and Y designate independently carbon or a heteroatom
A is a linking group between Z and Y comprising 0, 1, 2 or 3 atoms in the cycle wherein an addition product obtainable by addition of an acid halide of formula Ri-C (O)-X wherein X = fluorine, chlorine or bromine and Ri has the meaning given above, to a vinyl ether of formula (II) CH2 =CH-OR2 (II) wherein R2 is an alkyl group, an aralkyl group or an aryl group is reacted with a compound of formula (III) Y-A-Z (III), Z , Y and A are as defined above in the presence of hydrogen halide, in particular hydrogen chloride.
The definitions and preferences described above in the framework of the manufacturing process according to the invention equally apply to the synthesis process.
The following examples are intended to illustrate the invention in further detail without limiting its scope. Example 1 Manufacture of 6-(trifluoromethyl)pyrimidin-2( 1 H)-on To a solution of 8.74 moles of urea in 2.2L of methanol in a 3-necked flask, equipped with a mechanical stirrer, a reflux condenser and a dropping funnel was added dropwise over about 3 hours under N2 atmosphere an equimolar amount of 4-ethoxy- 1,1,1 -trifluoro-3-buten-2-one (ETFBO) which had been manufactured by addition of trifluoroacetyl chloride to ethyl vinyl ether. The temperature of the reaction mixture was kept below 150C.
After 15 min, 1.35 L of a concentrated HCl solution (32 %) was added to the cooled suspension obtained and a clear solution was obtained. The solution was slowly heated to 600C and after 2 hours stirring, a suspension was formed. After overnight stirring at 600C and subsequently 1 h stirring at 0 to 5°C, the precipitate was filtered off. The residue was washed with water until neutral pH and subsequently with hexane (ca. 500ml). After overnight drying on a rotary evaporator under reduced pressure in a 2L flask, 6-(trifluoromethyl)pyrimidin- 2(lH)-on was obtained as colorless cristals. The yield was 1.2 kg, (85 % of the theoretical yield). Example 2 Manufacture of 3-(trifluoromethyl) 1 H-pyrazole
To a solution of 4.4 moles hydrazine.hydrochloride in 2.2L of methanol in a 3 -necked flask, equipped with a mechanical stirrer, a reflux condenser and a dropping funnel an equimolar amount of ETFBO which had been manufactured by addition of trifluoroacetyl chloride to ethyl vinyl ether was added dropwise over about 4 hours under N2 atmosphere. The temperature of the reaction mixture was kept below 15°C. After 12h of reflux, the reaction batch was filtered in a 2L flask and concentrated under vacuum (An identical batch was made under the same conditions, yield of both crude products was ca. 95 %). Subsequently, the combined crude product was purified by shortpass-vacuum distillation at 27 mbar. The yield was 1105 g, which corresponded to 92 % of the theoretical yield. Example 3
Manufacture of 6-(trifluoromethyl)pyrimidin-2(lH)-on from CETFBO Synthesis of CETFBO : 4.0 moles of trifluoroacetyl chloride was condensed in a 3 -necked flask which was cooled at around -300C during ca. 2 hours. 4.0 moles of ethyl vinyl ether was added dropwise to the liquid trifluoroacetyl chloride cooled at around -300C during about 2.5 hours.
CETFBO could be obtained quantitatively without any elimination of HCl.
Synthesis of6-(trifluoromethyl)pyrimidin-2(lH)-on: 0.12 moles of the cooled solution of CETFBO was added dropwise to a stirred solution of 0.1 moles of urea in 25 mL of methanol in a 3-necked flask whereby the temperature was kept below 5°C. The solution was stirred overnight at room temperature. The brown colored solution obtained was then heated at 700C for 4,5 hours. Upon cooling the solution in an ice-bath,
6-(trifluoromethyl)pyrimidin-2( lH)-on was obtained as pale beige crystals which were filtered off and washed with water. After drying on a rotary evaporator under reduced pressure, 6-(trifluoromethyl)pyrimidin-2(lH)-on was obtained in 82 % yield. Example 4
Manufacture of 3-pyridinecarboxylic acid, l,2-dihydro-2-oxo-6-
(trifluoromethyl)-methyl ester (MTFPMOC)
420 mmoles of methylmalonamide (MMA) was added to ice cooled triethylamine (420 mmoles) over a period of about 20 min under vigerous stirring. ETFBO which had been manufactured by addition of TFAC to ethyl vinyl ether, was then added dropwise under ice cooling and over a period of about 30 min whereby the temperature of the reaction mixture was kept under 100C. The reaction mixture was then further stirred at room temperature for 20 h. A concentrated HCl solution (2N) was added to the solution until a pH of 3 was obtained. After extraction of the solution with ethyl acetate, the organic phase was washed with water and dried over sodium sulfate. After removing the volatile compounds on a rotary evaporator, the crude product could be obtained in 86 % yield. After crystallisation from methano I/water, MTFPMOC was obtained with a purity > 98% (GC). Example 5
Manufacture of 3-Pyridinecarboxylic acid, l,2-dihydro-2-oxo-6- (trifluoromethyl)- ethyl ester (ETFPMOC)
420 mmoles of ethylmalonamide (EMA) was added to ice cooled triethylamine (420 mmoles) over a period of about 20 min under vigerous stirring. ETFBO which had been manufactured by addition of TFAC to ethyl vinyl ether, was then added dropwise under ice cooling and over a period of about 30 min whereby the temperature of the reaction mixture was kept under 100C. The reaction mixture was then further stirred at room temperature for 20 h. A concentrated HCl solution (2N) was added to the solution until a pH of 3 was obtained. After extraction of the solution with ethylacetate, the organic phase was washed with water and dried over sodium sulfate. After removing the volatile compounds on a rotary evaporator, the crude product could be obtained in 86 % yield. After crystallisation from methano I/water, ETFPMOC was obtained with a purity > 98% (GC).

Claims

C L A I M S
1. A process for the manufacture of a cyclic compound of formula (I) :
Figure imgf000011_0001
wherein Ri is a halogenated alkyl group Z and Y designate independently carbon or a heteroatom
A is a linking group between Z and Y comprising 0, 1, 2 or 3 atoms in the cycle
which comprises (a) adding an acid halide of formula Ri-C (O)-X wherein X = fluorine, chlorine or bromine and Ri has the meaning given above, to a vinyl ether of formula (II) CH2 =CH-OR2 (II) wherein R2 is an alkyl group, an aralkyl group or an aryl group to produce an addition product and (b) said addition product is reacted with a compound of formula (III) Y-A-Z (III), Z , Y and A are as defined above.
2. The process according to claim 1, wherein Rl is a Cl to C3 halogenated alkyl group preferably selected from CF3, CF2H and CF2Cl.
3. The process according to claim 1 or 2, wherein the addition product comprises a compound of formula (IV) :
Figure imgf000011_0002
wherein Ri is a halogenated alkyl group preferably selected from CF3, CF2H and CF2Cl
X is Cl or Br and
R2 is an alkyl group, an aralkyl group or an aryl group.
4. The process according to claim 3, wherein the addition product comprises a compound of formula (V) :
Figure imgf000012_0001
wherein R2 is an alkyl group, an aralkyl group or an aryl group.
5. The process according to anyone of claims 1 to 4, wherein the addition product comprises a compound of formula (VI) :
Figure imgf000012_0002
wherein Ri is a halogenated alkyl group preferably selected from CF3, CF2H and CF2Cl R2 is an alkyl group, an aralkyl group or an aryl group.
6. The process according to claim 5, wherein the addition product comprises a compound of formula (VII) :
Figure imgf000012_0003
wherein R2 is an alkyl group, an aralkyl group or an aryl group.
7. The process according to anyone of claims 1 to 6, wherein R2 is a Cl to C4 alkyl group, preferably an ethyl group.
8. The process according to anyone of claims 1 to 7, wherein Z and Y are independently selected from oxygen, sulphur, nitrogen and carbon.
9. The process according to claim 8, wherein at least one of Z and Y is nitrogen.
10. The process according to anyone of claims 1 to 9 wherein A comprises 1 or 2 catenary carbon atoms.
11. The process according to anyone of claims 1 to 10, wherein the compound of formula (III) is selected from hydrazine or its hydrate or hydrochloride, urea, thiourea, malonic acid monoamide and malomononitrile.
12. The process according to anyone of claims 1 to 11, wherein the compound of formula (I) corresponds to one of the formulae
Figure imgf000013_0001
X
IX wherein A comprises 1 catenary/annular atoms, optionally substituted carbon atoms
wherein R3 is H or a Cl to C6 alkyl.
13. The process according to anyone of claims 1 to 12, wherein HX produced in step (a) is fed to step (b).
14. The process according to anyone of claims 1 to 13, wherein the addition product supplied to step (b) is a crude product from step (a).
15. The process according to anyone of claims 1 to 14, wherein the reaction of step (b) is carried out at a temperature in the range from -15°C to +800C.
16. The process according to anyone of claims 1 to 15, which further comprises isolating the compound of formula (I) from the reaction medium of step (b) by solid/liquid separation or distillation.
17. Use of a compound of formula (IV) :
Figure imgf000014_0001
wherein Ri is a halogenated alkyl group preferably selected from CF3, CF2H and CF2Cl
X is Cl or Br
R2 is an alkyl group, an aralkyl group or an aryl group as reagent in an addition reaction to form a cyclic compound.
PCT/EP2009/062462 2008-09-30 2009-09-25 Process for the synthesis of halogenated cyclic compounds WO2010037688A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CN2009801384364A CN102164898A (en) 2008-09-30 2009-09-25 Process for the synthesis of halogenated cyclic compounds
US13/120,505 US8431710B2 (en) 2008-09-30 2009-09-25 Process for the synthesis of halogenated cyclic compounds
KR1020197018768A KR20190080972A (en) 2008-09-30 2009-09-25 Process for the synthesis of halogenated cyclic compounds
JP2011529509A JP6180705B2 (en) 2008-09-30 2009-09-25 Method for the synthesis of halogenated cyclic compounds
KR1020167031136A KR20160131129A (en) 2008-09-30 2009-09-25 Process for the synthesis of halogenated cyclic compounds
CA2735921A CA2735921C (en) 2008-09-30 2009-09-25 Process for the synthesis of halogenated cyclic compounds
EP09783436.0A EP2334645B1 (en) 2008-09-30 2009-09-25 Process for the synthesis of fluorinated cyclic compounds
US13/872,860 US8981115B2 (en) 2008-09-30 2013-04-29 Process for the synthesis of halogenated cyclic compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08165547 2008-09-30
EP08165547.4 2008-09-30

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US13/120,505 A-371-Of-International US8431710B2 (en) 2008-09-30 2009-09-25 Process for the synthesis of halogenated cyclic compounds
US13/872,860 Continuation US8981115B2 (en) 2008-09-30 2013-04-29 Process for the synthesis of halogenated cyclic compounds

Publications (1)

Publication Number Publication Date
WO2010037688A1 true WO2010037688A1 (en) 2010-04-08

Family

ID=40351699

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/062462 WO2010037688A1 (en) 2008-09-30 2009-09-25 Process for the synthesis of halogenated cyclic compounds

Country Status (7)

Country Link
US (2) US8431710B2 (en)
EP (1) EP2334645B1 (en)
JP (5) JP6180705B2 (en)
KR (3) KR20110066201A (en)
CN (2) CN106083710B (en)
CA (1) CA2735921C (en)
WO (1) WO2010037688A1 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8426650B2 (en) 2009-07-06 2013-04-23 Solvay Sa Process for the manufacture of halogenated precursors of alkenones in the presence of a solvent
US8431710B2 (en) 2008-09-30 2013-04-30 Solvay Sa Process for the synthesis of halogenated cyclic compounds
US8519195B2 (en) 2008-07-04 2013-08-27 Solvay Sa Process for the manufacture of alkenones
EP2662359A1 (en) 2012-05-08 2013-11-13 Solvay Sa Ionic Liquids, Method for manufacturing thereof, and Electrochemical Devices Comprising the Same
WO2014029786A1 (en) * 2012-08-22 2014-02-27 Solvay Sa Process for the manufacture of alkenones
WO2014096284A1 (en) 2012-12-20 2014-06-26 Solvay Sa Salts of n-containing heterocyclic anions as components in electrolytes
WO2014202599A1 (en) * 2013-06-20 2014-12-24 Basf Se Process for preparing pyridylpyrazole compounds and derivatives thereof from pyridylhydrazine
US8957254B2 (en) 2009-07-06 2015-02-17 Solvay Sa Process for chemical synthesis from an alkenone made from a halogenated precursor
EP2987782A1 (en) 2014-08-22 2016-02-24 Solvay SA Distillation process comprising at least two distillation steps to obtain purified halogenated carboxylic acid halide, and use of the purified halogenated carboxylic acid halide
WO2016079122A1 (en) 2014-11-17 2016-05-26 Solvay Sa A method for producing a chemical compound and apparatus therefor
WO2016079126A1 (en) 2014-11-17 2016-05-26 Solvay Sa Distillation process comprising at least two distillation steps to obtain purified halogenated carboxylic acid halide, and use of the purified halogenated carboxylic acid halide
EP3031791A1 (en) 2014-12-10 2016-06-15 Solvay SA Halogenation process of 1,1-dihaloethene
EP3199522A1 (en) 2016-02-01 2017-08-02 Solvay SA Aminothioate derivatives, production thereof and use
WO2019043238A1 (en) 2017-09-04 2019-03-07 Solvay Sa Process and intermediate for the manufacture of difluoroacetyl chloride
EP3650443A1 (en) 2018-11-07 2020-05-13 Fujian Yongjing Technology Co., Ltd. Continuous flow synthesis of fluorinated or non-fluorinated pyrazoles
WO2021152055A1 (en) 2020-01-31 2021-08-05 Solvay Sa Process for the manufacture of haloalkyl substituted pyridine compounds

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0903749D0 (en) * 2009-03-04 2009-04-15 Syngenta Participations Ag Chemical process
US11390587B2 (en) * 2018-12-27 2022-07-19 Corteva Agriscience Llc Preparation of sulfonamide herbicide process intermediates
JP2021079146A (en) * 2021-02-22 2021-05-27 株式会社三洋物産 Game machine
JP7315071B2 (en) * 2021-03-03 2023-07-26 株式会社三洋物産 game machine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0163280A1 (en) * 1984-05-30 1985-12-04 BASF Aktiengesellschaft Pyrimidylphosphoric acid esters, process for their preparation and their use for pest control

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0502740B1 (en) * 1991-03-07 1998-05-27 E.I. Du Pont De Nemours And Company Herbicidal pyridine sulfonamide
US5235060A (en) * 1991-07-11 1993-08-10 E. I. Du Pont De Nemours And Company Certain three component ionic substituted pyridine compounds as intermediates for preparation as herbicides
DE4128828A1 (en) 1991-08-30 1993-03-04 Basf Ag AMMONIUM OR UREA-CONTAINED DISPENSERS AND METHOD FOR THEIR PRODUCTION
WO1994008994A1 (en) 1992-10-13 1994-04-28 Smithkline Beecham Plc Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists
EP0659729B1 (en) * 1993-12-23 1998-06-24 Solvay Fluor und Derivate GmbH Process for preparing chlorides of polyfluorochloro- and perfluoro carboxylic acids in the presence of chlorine
JP3843152B2 (en) * 1995-08-08 2006-11-08 石原産業株式会社 Process for producing 4-alkoxy-1,1,1-trifluoro-3-buten-2-one
GB2305174A (en) * 1995-09-15 1997-04-02 Zeneca Ltd Chemical process
GB9711114D0 (en) * 1997-05-29 1997-07-23 Merck Sharp & Dohme Therapeutic agents
DE19821088A1 (en) 1998-05-12 1999-11-18 Basf Ag New polyaspartic acids modified with pyrazole compounds, useful as stable nitrification inhibitors for addition to mineral fertilizers
WO2002053518A2 (en) 2000-12-29 2002-07-11 Honeywell International, Inc. HALOGENATED-α,β-UNSATURATED-β-(SUBSTITUTED-AMINO) CARBOXYLATE ESTERS
JP4673293B2 (en) 2003-03-07 2011-04-20 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト Process for the production of substituted nicotinic acid esters
DE10325715A1 (en) 2003-06-06 2004-12-23 Solvay Fluor Und Derivate Gmbh Simplified production of alkenones
US20060128702A1 (en) 2004-11-23 2006-06-15 Manojit Pal Heterocyclic and bicyclic compounds, compositions and methods
DE102004061593A1 (en) 2004-12-21 2006-06-22 Abbott Gmbh & Co. Kg Substituted N-heterocyclic compounds and their therapeutic use
EP1940842B1 (en) 2005-09-29 2012-05-30 Merck Sharp & Dohme Corp. Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
WO2007088876A1 (en) * 2006-02-02 2007-08-09 Kumiai Chemical Industry Co., Ltd. Pyridone derivative and herbicide
EP2422790A1 (en) * 2007-02-09 2012-02-29 Emory University Paramyxovirus family inhibitors and methods of use thereof
EP1987717A1 (en) * 2007-04-30 2008-11-05 Bayer CropScience AG Pyridon carboxamides, agents containing these but not impacting useful plants and method for their manufacture and application
EP2008996A1 (en) 2007-06-27 2008-12-31 Syngeta Participations AG Process for the production of pyrazoles
WO2010002577A1 (en) * 2008-07-01 2010-01-07 Dow Agrosciences Llc Improved process for the preparation of 2-trifluoromethyl-5-(1-substituted)alkylpyridines
US8519195B2 (en) 2008-07-04 2013-08-27 Solvay Sa Process for the manufacture of alkenones
EP2154167A1 (en) * 2008-07-30 2010-02-17 Bayer MaterialScience AG Electromechanical converter with a polymer element on a polyisocyanate basis
KR20110066201A (en) * 2008-09-30 2011-06-16 솔베이(소시에떼아노님) Process for the synthesis of halogenated cyclic compounds
CN102471202B (en) 2009-07-06 2015-10-07 索尔维公司 Manufacture the method for the halogenated precursors of ketenes in the presence of solvent
CN102471201A (en) 2009-07-06 2012-05-23 索尔维公司 Process for the manufacture of halogenated precursors of alkenones under specific conditions
EP2451764B1 (en) 2009-07-06 2016-01-13 Solvay Sa Process for the manufacture of alkenones
JP6194245B2 (en) * 2013-12-27 2017-09-06 株式会社Ｓｕｂａｒｕ Traffic light recognition device

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0163280A1 (en) * 1984-05-30 1985-12-04 BASF Aktiengesellschaft Pyrimidylphosphoric acid esters, process for their preparation and their use for pest control

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
AGENOR COLLA ET AL: "Trihaloacetylated enol ethers - General synthetic procedure and heterocyclic ring closure reactions with hydroxylamine", SYNTHESIS, GEORG THIEME VERLAG, STUTTGART, DE, 1991, pages 483 - 486, XP000196317, ISSN: 0039-7881 *
FRANZ EFFENBERGER ET AL: "Die Acylierung von Enolethern mit reaktiven Carbonsäurechloriden", CHEMISCHE BERICHTE, VERLAG CHEMIE GMBH. WEINHEIM, DE, vol. 115, 1982, pages 2766 - 2782, XP002295515, ISSN: 0009-2940 *
MANFRED SCHLOSSER ET AL: "Switchable reactivity: the site-selective functionalization of trifluoromethyl-substituted pyrazoles", EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, WILEY-VCH VERLAG, WEINHEIM, DE, no. 17, 2002, pages 2913 - 2920, XP002462801, ISSN: 1434-193X *
MARINE G. GORBUNOVA ET AL: "Synthesis and properties of ß-ethoxyvinyl polyfluoroalkyl ketones", SYNTHESIS, GEORG THIEME VERLAG, STUTTGART, DE, no. 5, 2000, pages 738 - 742, XP002295516, ISSN: 0039-7881 *

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8519195B2 (en) 2008-07-04 2013-08-27 Solvay Sa Process for the manufacture of alkenones
US8431710B2 (en) 2008-09-30 2013-04-30 Solvay Sa Process for the synthesis of halogenated cyclic compounds
US8981115B2 (en) 2008-09-30 2015-03-17 Solvay Sa Process for the synthesis of halogenated cyclic compounds
US8957254B2 (en) 2009-07-06 2015-02-17 Solvay Sa Process for chemical synthesis from an alkenone made from a halogenated precursor
US8426650B2 (en) 2009-07-06 2013-04-23 Solvay Sa Process for the manufacture of halogenated precursors of alkenones in the presence of a solvent
EP2662359A1 (en) 2012-05-08 2013-11-13 Solvay Sa Ionic Liquids, Method for manufacturing thereof, and Electrochemical Devices Comprising the Same
WO2013167586A1 (en) 2012-05-08 2013-11-14 Solvay Sa Ionic liquids, method for manufacturing thereof, and electrochemical devices comprising the same
US9365480B2 (en) 2012-08-22 2016-06-14 Solvay Sa Process for the manufacture of alkenones
WO2014029786A1 (en) * 2012-08-22 2014-02-27 Solvay Sa Process for the manufacture of alkenones
WO2014096284A1 (en) 2012-12-20 2014-06-26 Solvay Sa Salts of n-containing heterocyclic anions as components in electrolytes
WO2014202599A1 (en) * 2013-06-20 2014-12-24 Basf Se Process for preparing pyridylpyrazole compounds and derivatives thereof from pyridylhydrazine
EP2987782A1 (en) 2014-08-22 2016-02-24 Solvay SA Distillation process comprising at least two distillation steps to obtain purified halogenated carboxylic acid halide, and use of the purified halogenated carboxylic acid halide
US10017452B2 (en) 2014-08-22 2018-07-10 Solvay Sa Distillation process comprising at least two distillation steps to obtain purified halogenated carboxylic acid halide, and use of the purified halogenated carboxylic acid halide
WO2016079126A1 (en) 2014-11-17 2016-05-26 Solvay Sa Distillation process comprising at least two distillation steps to obtain purified halogenated carboxylic acid halide, and use of the purified halogenated carboxylic acid halide
WO2016079122A1 (en) 2014-11-17 2016-05-26 Solvay Sa A method for producing a chemical compound and apparatus therefor
EP3031791A1 (en) 2014-12-10 2016-06-15 Solvay SA Halogenation process of 1,1-dihaloethene
EP3199522A1 (en) 2016-02-01 2017-08-02 Solvay SA Aminothioate derivatives, production thereof and use
WO2019043238A1 (en) 2017-09-04 2019-03-07 Solvay Sa Process and intermediate for the manufacture of difluoroacetyl chloride
EP3650443A1 (en) 2018-11-07 2020-05-13 Fujian Yongjing Technology Co., Ltd. Continuous flow synthesis of fluorinated or non-fluorinated pyrazoles
US11299463B2 (en) 2018-11-07 2022-04-12 Fujian Yongjing Technology Co., Ltd. Process for the manufacture of pyrazoles or pyrimidones
WO2021152055A1 (en) 2020-01-31 2021-08-05 Solvay Sa Process for the manufacture of haloalkyl substituted pyridine compounds

Also Published As

Publication number Publication date
US20130237710A1 (en) 2013-09-12
KR20190080972A (en) 2019-07-08
JP6511346B2 (en) 2019-05-15
JP2018058869A (en) 2018-04-12
JP2020023533A (en) 2020-02-13
EP2334645A1 (en) 2011-06-22
KR20160131129A (en) 2016-11-15
KR20110066201A (en) 2011-06-16
CA2735921C (en) 2017-03-21
CN106083710B (en) 2021-03-12
CN102164898A (en) 2011-08-24
EP2334645B1 (en) 2019-11-06
US8981115B2 (en) 2015-03-17
CN106083710A (en) 2016-11-09
JP2022028792A (en) 2022-02-16
US8431710B2 (en) 2013-04-30
US20110178297A1 (en) 2011-07-21
CA2735921A1 (en) 2010-04-08
JP2015227339A (en) 2015-12-17
JP2012504153A (en) 2012-02-16
JP6647268B2 (en) 2020-02-14
JP6180705B2 (en) 2017-08-16

Similar Documents

Publication Publication Date Title
CA2735921C (en) Process for the synthesis of halogenated cyclic compounds
CA2607934C (en) Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids
EP1723156A1 (en) Process for the preparation of pyridine derivatives
US7847117B2 (en) Process for preparing alkyl(methoxymethyl)trimethylsilanylmethylamines
US5925764A (en) Process and intermediated for the manufacture of pyridine-2, 3-dicarboxylate compounds
US7772395B2 (en) Process for the preparation of phenyl 2-pyrimidinyl ketones and their novel intermediates
US6320053B1 (en) Preparation of heteroarylcarboxamides
US6080867A (en) Process and intermediates for the manufacture of pyridine-2,3-dicarboxylate compounds
US5663365A (en) Process for the preparation of pyrazolones
JPH11130752A (en) Production of heteroaryl carboxylic amide and ester
JP2991832B2 (en) Method for producing pyrimidine derivative
US6462195B1 (en) Methods for highly selectively o-alkylating amide compounds with the use of copper salts
JPH02101064A (en) Production of pyrazole carboxylic acid amides
JPH0478632B2 (en)

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980138436.4

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09783436

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009783436

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2735921

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 13120505

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2011529509

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2737/CHENP/2011

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 20117009786

Country of ref document: KR

Kind code of ref document: A